StarHub vs M1 Kliniken Which Is More Lucrative?

StarHub and M1 Kliniken are two companies operating in different sectors of the economy, but both are publicly traded stocks that have attracted the attention of investors. StarHub is a telecommunications company based in Singapore, offering a range of services including mobile, broadband, and TV. M1 Kliniken, on the other hand, is a German-based healthcare company specializing in aesthetic and dental treatments. Both stocks have shown potential for growth and profitability, making them interesting investments for those looking to diversify their portfolio.

StarHub or M1 Kliniken?

When comparing StarHub and M1 Kliniken, different investors may prioritize various metrics based on their investment strategies and goals. So, ask yourself what type of investor you are. This will guide you in determining which metrics are most important for your investment decision between StarHub and M1 Kliniken.

Dividend Investors:

Dividend investors look for stable and growing income streams, using dividend metrics to assess potential investments. A company's dividend yield essentially measures the size of its dividend relative to the total market value of the company. StarHub has a dividend yield of 5.9%, while M1 Kliniken has a dividend yield of 3.06%. Beyond the yield itself, considering the growth and sustainability of these dividends is also crucial. StarHub reports a 5-year dividend growth of -20.76% year and a payout ratio of 79.48%. On the other hand, M1 Kliniken reports a 5-year dividend growth of 0.00% year and a payout ratio of 11.82%.

Value Investors:

Value investors focus on financial metrics to determine a stock's intrinsic value compared to its market value. The Price-to-Earnings (P/E) Ratio links stock price to a company's earnings per share, with StarHub P/E ratio at 14.36 and M1 Kliniken's P/E ratio at 18.23. Another crucial valuation metric is the Price-to-Book (P/B) Ratio, which compares stock price with book value per share. StarHub P/B ratio is 3.85 while M1 Kliniken's P/B ratio is 2.79.

Growth Investors:

Growth investors prioritize metrics indicative of a company's expansion potential. Focusing on top-line growth, StarHub has seen a 5-year revenue growth of 0.01%, while M1 Kliniken's is 3.26%. Return on Equity (ROE) measures how effectively a company uses equity investment to generate earnings, with StarHub's ROE at 27.03% and M1 Kliniken's ROE at 15.05%.

Retail Investors:

Retail investors often consider stock affordability and company familiarity. For example, day low prices are S$1.21 for StarHub and €16.25 for M1 Kliniken. Over the past year, StarHub's prices ranged from S$1.04 to S$1.29, with a yearly change of 24.04%. M1 Kliniken's prices fluctuated between €9.90 and €22.40, with a yearly change of 126.26%. Brand recognition also plays a role, as familiarity with a company can influence investment decisions.